News

Article

PQRI Risk-Management Case Studies: HACCP Training Tool Guidance

External Link - article-727768.pdf

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Related Videos
Benjamin McLeod and Sebastian Lykke Skafte Andersen go behind the headlines to examine the motivations behind recent M&A activity, tariff responses, and more.
Related Content
New Year, Same Challenges: Pharma’s Ongoing Struggle with FDA 483s
August 29th 2025

New Year, Same Challenges: Pharma’s Ongoing Struggle with FDA 483s

Patrick Falvey Georgia Sloboda Sarah DeDonder Lauren Schoukroun-Barnes
Drug Solutions Podcast: Growth and Advancements in Fill/Finish
August 29th 2025

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
Lung with tuberculosis, long covid or asthma disease, cancer cells, virus and air pollution, no tobacco day, organ donation | Image Credit: © Berit Kessler - stock.adobe.com
August 29th 2025

Cereno Scientific’s PAH Treatment Gets FDA Fast Track Status

Patrick Lavery
Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail
August 29th 2025

Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail

Felicity Thomas
Specification Equivalence: A Practical Approach to Method and Acceptance Criteria Equivalence
August 29th 2025

Specification Equivalence: A Practical Approach to Method and Acceptance Criteria Equivalence

Gail Reed Joseph A. Albanese Yelena Ionova J. Mark Wiggins
Feb 19, 2020 Foster City / CA / USA - Gilead sign at their headquarters in Silicon Valley; Gilead Sciences, Inc. is an American biotechnology company that researches, develops and commercializes drugs | Image Credit: © Sundry Photography - stock.adobe.com
August 29th 2025

Gilead Sciences’ HIV PrEP Injectable Approved by European Commission

Patrick Lavery